Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
All-trans retinoic acid (ATRA) has only limited single agent activity in AML without the PML-RARα fusion (non-M3 AML). In search of a sensitizing strategy to overcome this relative ATRA resistance, we investigated the potency of the HDAC class-I selective inhibitor entinostat in AML cell lines Kasum...
Main Authors: | Nadja Blagitko-Dorfs, Yi Jiang, Jesús Duque-Afonso, Jan Hiller, Arzu Yalcin, Gabriele Greve, Mahmoud Abdelkarim, Björn Hackanson, Michael Lübbert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3792939?pdf=render |
Similar Items
-
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
by: Narendra Bharathy, et al.
Published: (2019-05-01) -
Genetic and epigenetic profiles of elderly AML
by: Santos Silva, Patricia Alexandra
Published: (2019) -
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
by: Johanna K. Freundt, et al.
Published: (2019-03-01) -
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
by: Lars Ny, et al.
Published: (2021-08-01) -
Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
by: Sebastian Klobuch, et al.
Published: (2018-11-01)